| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SIENTRA INC | 2,199,012 | 42,045,000 | 17.88% | ||
| 2 | PARATEK PHARMACEUTICALS INC | 1,301,413 | 40,057,000 | 17.03% | ||
| 3 | SUPERNUS PHARMACEUTICALS INC COM | 2,303,462 | 27,826,000 | 11.83% | ||
| 4 | Dicerna Pharmaceuticals | 972,734 | 23,355,000 | 9.93% | ||
| 5 | Proteon Therapeutics | 2,017,872 | 22,661,000 | 9.64% | ||
| 6 | AMARIN CORP PLC | 8,087,486 | 18,925,000 | 8.05% | ||
| 7 | CEMPRA INC | 524,285 | 17,988,000 | 7.65% | ||
| 8 | LOMBARD MEDICAL INC | 3,473,452 | 13,199,000 | 5.61% | ||
| 9 | PORTOLA PHARMACEUTICALS INC | 347,349 | 13,185,000 | 5.61% | ||
| 10 | REGULUS THERAPEUTICS INC | 327,350 | 5,542,000 | 2.36% | ||
| 11 | ZOGENIX INC | 2,335,218 | 3,199,000 | 1.36% | ||
| 12 | HYPERION THERAPEUTICS INC | 62,500 | 2,868,000 | 1.22% | ||
| 13 | ANTHERA PHARMACEUTICALS I | 437,994 | 1,958,000 | 0.83% | ||
| 14 | OncoGenex Pharmaceuticals Inc | 603,740 | 1,274,000 | 0.54% | ||
| 15 | CHEMOCENTRYX INC | 109,700 | 824,000 | 0.35% | ||
| 16 | FLEX PHARMA INC COM | 10,000 | 200,000 | 0.09% | ||
| 17 | Epirus Biopharma | 7,896 | 70,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-005781, filed 2015.05.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
